Literature DB >> 11294289

Hepatocyte transplantation: new horizons and challenges.

H Malhi1, S Gupta.   

Abstract

Hepatocyte transplantation represents an alternative strategy for treating liver disease. Liver repopulation following acute liver failure could, potentially, eliminate the requirement for orthotopic liver transplantation. Similarly, the ability to repopulate the liver with disease-resistant hepatocytes offers new opportunities for correcting genetic disorders and treating patients with chronic liver disease. Recent advances concerning the fate of transplanted cells in the recipient liver, the efficacy of cell therapy in outstanding animal models of human disease. and the isolation of progenitor liver cells capable of differentiating into mature hepatocytes have renewed optimism in regard to treating people with hepatocyte transplantation. Recruitment of an increasing number of investigators to the field and the success of recent pilot studies indicate that hepatocyte transplantation will become routine clinical practice in the near future.

Entities:  

Mesh:

Year:  2001        PMID: 11294289     DOI: 10.1007/s005340170049

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  12 in total

Review 1.  Hepatocyte transplantation for inborn errors of metabolism.

Authors:  A B Burlina
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Diminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation.

Authors:  Zhu Shi; Xiu-Ling Liang; Bing-Xun Lu; Su-Yue Pan; Xi Chen; Qi-Qiang Tang; Ying Wang; Fan Huang
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

3.  Adhesive stem cell coatings for enhanced retention in the heart tissue.

Authors:  Pei-Jung Wu; Hsuan Peng; Cong Li; Ahmed Abdel-Latif; Brad J Berron
Journal:  ACS Appl Bio Mater       Date:  2020-04-22

4.  Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin.

Authors:  Yogesh-K Vashist; Celine Tiffon; Christoforos Stoupis; Claudio-A Redaelli
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

5.  Hepatic proliferation in Gunn rats transplanted with hepatocytes: effect of retrorsine and tri-iodothyronine.

Authors:  F J Cubero; P Maganto; N Mula; A Ortiz; M G Barrutia; F J Codesal; R M Arahuetes
Journal:  Cell Prolif       Date:  2005-06       Impact factor: 6.831

6.  Differentiation of human embryonic stem cells along a hepatic lineage.

Authors:  Stephanie M Zamule; Denise M Coslo; Fengming Chen; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2011-01-15       Impact factor: 5.192

7.  Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation.

Authors:  Harmeet Malhi; Giridhar R Gorla; Adil N Irani; Pallavi Annamaneni; Sanjeev Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

8.  Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.

Authors:  Tom K Kuo; Shun-Pei Hung; Chiao-Hui Chuang; Chien-Tsun Chen; Yu-Ru V Shih; Szu-Ching Y Fang; Vincent W Yang; Oscar K Lee
Journal:  Gastroenterology       Date:  2008-03-12       Impact factor: 22.682

Review 9.  Development of hepatic tissue engineering.

Authors:  Henning Cornelius Fiegel; Ulrich Kneser; Dietrich Kluth; Roman Metzger; Holger Till; Udo Rolle
Journal:  Pediatr Surg Int       Date:  2009-06-02       Impact factor: 1.827

Review 10.  Fetal and adult liver stem cells for liver regeneration and tissue engineering.

Authors:  H C Fiegel; Claudia Lange; U Kneser; W Lambrecht; A R Zander; X Rogiers; D Kluth
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.